Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Marija Kosić"'
Autor:
Marija Kosić, Zorica Nešić, Sofija Glumac, Marko Vasić, Vladislav Pajović, Bojana Savić, Nina Japundžić-Žigon
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 145, Iss , Pp 112411- (2022)
Doxorubicin (DOX) is an effective anticancer drug. However, its use is hampered by the development of very mortal cardiomyopathy. Here, we investigate whether the co-administration of the antidepressant paroxetine (P), known to exert beneficial cardi
Externí odkaz:
https://doaj.org/article/ae3305f41fc244d78b45f5e1dcb8c74c
Autor:
Marko Vasić, Zorica Nesic, Sofija Glumac, Nina Japundžić-Žigon, Bojana Savić, Marija Kosić, Vladislav Pajović
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 145, Iss, Pp 112411-(2022)
Doxorubicin (DOX) is an effective anticancer drug. However, its use is hampered by the development of very mortal cardiomyopathy. Here, we investigate whether the co-administration of the antidepressant paroxetine (P), known to exert beneficial cardi
Autor:
Marko Vasić, Csenger Kovácsházi, Marija Kosić, Vladislav Pajović, Gábor B. Brenner, Zoltán Giricz, Péter Ferdinandy, Dragana Bajic, Ljiljana Đukić, Nina Japundžić-Žigon
Publikováno v:
Toxicology and applied pharmacology. 423
Cardiomyopathy resistant to treatment is the most serious adverse effect of doxorubicin (dox). The mechanisms of dox-induced cardiomyopathy (DCM) have been extensively studied in dilated forms of DCM. However, efficient treatment did not emerge. The